Skip to main content
Top
Published in: Clinical Rheumatology 8/2007

01-08-2007 | Original Article

Peripheral neuropathy in Behçet disease: an electroneurophysiological study

Authors: Lale Akbulut, Gunes Gur, Hatice Bodur, Nuran Alli, Pınar Borman

Published in: Clinical Rheumatology | Issue 8/2007

Login to get access

Abstract

The aim of this study was to determine the peripheral nerve involvement electrophysiologically in Behçet patients without clinically evident neurological signs and symptoms. Sixty-three patients who fulfilled the International Study Group Classification Criteria for Behçet’s disease (BD) and 49 healthy control subjects were enrolled to the study. Conventional electrophysiological studies of peripheral nerves including F latencies were performed to all subjects. Thirty-one male and 32 female Behçet patients with a mean age of 33.6 ± 11.1 years and (22 male and 27 female healthy control subjects with a mean age of 35.8 ± 9.9 years were included to the study. All but four of the patients were active. In the BD group, electrophysiologically diagnosed neuropathy was detected in nine (14.28%) patients. One (1.58%) patient had sensorimotor polyneuropathy, one patient (1.58%) had sural and ulnar sensorimotor neuropathy, three (4.75%) patients had median and one patient (1.58%) had ulnar sensorimotor neuropathy. Sural nerve sensorial action potential was unobtainable in two (3.17%) patients and prolonged F latencies were observed in two (3.17%) patients. In the control group only one subject (2.4%) had low sural sensorial conduction velocity. The frequency of neuropathy was higher in the patients with BD when compared with the control subjects. Sensory nerves were affected more prominently than motor nerves. There was no relationship between the clinical and laboratory characteristics of the patients and the electrophysiologic findings. No significant difference was observed between the clinical parameters of the patients with and without electrophysiologically detected neuropathy, except the levels of disease duration (8.8 ± 5.1 vs 5.28 ± 4.3 years, respectively, p < 0.05). In conclusion, Behçet patients may have subclinical peripheral nerve involvement. Conventional electrophysiologic nerve conduction studies including F responses are recommended in routine examination to diagnose early neuropathy in Behçet patients without evident neurologic symptoms.
Literature
1.
go back to reference Behçet H (1937) Uber rezidivierende aphthouse durch ein virus verursachte Geschwuere am Mund, am Auge, und an den Genitalien. Dermatol Wochenschr 105:1152–1157 Behçet H (1937) Uber rezidivierende aphthouse durch ein virus verursachte Geschwuere am Mund, am Auge, und an den Genitalien. Dermatol Wochenschr 105:1152–1157
2.
go back to reference Kaklamani VG, Vaiopoulus G, Kaklamanis PG (1998) Behçet’s disease. Semin Arthritis Rheum 27:197–215PubMedCrossRef Kaklamani VG, Vaiopoulus G, Kaklamanis PG (1998) Behçet’s disease. Semin Arthritis Rheum 27:197–215PubMedCrossRef
3.
go back to reference Önder M, Gurer MA (1997) The multiple faces of Behçet’s disease and its aetiological factors. Yonsei Med J 38:423–427 Önder M, Gurer MA (1997) The multiple faces of Behçet’s disease and its aetiological factors. Yonsei Med J 38:423–427
4.
go back to reference Serdaroğlu P, Yazıcı H, Özdemir C, Yurdakul S, Bahar S, Aktin E (1989) Neurologic involvement in Behçet’s syndrome. Arch Neurol 46:265–269PubMed Serdaroğlu P, Yazıcı H, Özdemir C, Yurdakul S, Bahar S, Aktin E (1989) Neurologic involvement in Behçet’s syndrome. Arch Neurol 46:265–269PubMed
5.
go back to reference Siva A, Kantarci OH, Saip S, Altintas A, Hamuryudan V, Islak C, Kocer N, Yazıcı H (2001) Behçet’s disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 248:95–103PubMedCrossRef Siva A, Kantarci OH, Saip S, Altintas A, Hamuryudan V, Islak C, Kocer N, Yazıcı H (2001) Behçet’s disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 248:95–103PubMedCrossRef
6.
go back to reference Kidd D, Steuer A, Denman AM, Rudge P (1999) Neurological complications in Behçet’s syndrome. Brain 122:2183–2194PubMedCrossRef Kidd D, Steuer A, Denman AM, Rudge P (1999) Neurological complications in Behçet’s syndrome. Brain 122:2183–2194PubMedCrossRef
7.
go back to reference Lannuzel A, Lamaury I, Charpentier D, Caparros-Lefebvre D (2002) Neurological manifestations of Behçet’s disease in a Caribbean population: clinical and imaging findings. J Neurol 249:410–418PubMedCrossRef Lannuzel A, Lamaury I, Charpentier D, Caparros-Lefebvre D (2002) Neurological manifestations of Behçet’s disease in a Caribbean population: clinical and imaging findings. J Neurol 249:410–418PubMedCrossRef
8.
go back to reference Namer IJ, Karabudak R, Zileli T, Ruacan Ş, Küçükali T, Kansu E (1987) Peripheral Nervous system involvement in Behçet’s disease: case report and review of the literature. Eur Neurol 26:235–240PubMed Namer IJ, Karabudak R, Zileli T, Ruacan Ş, Küçükali T, Kansu E (1987) Peripheral Nervous system involvement in Behçet’s disease: case report and review of the literature. Eur Neurol 26:235–240PubMed
9.
go back to reference Takeuchi A, Kodama M, Takatsu M, Hashimoto T, Miyashita H (1989) Mononeuritis multiplex in incomplete Behçet’s disease: a case report and review of the literature. Clin Rheumatol 8:375–380PubMedCrossRef Takeuchi A, Kodama M, Takatsu M, Hashimoto T, Miyashita H (1989) Mononeuritis multiplex in incomplete Behçet’s disease: a case report and review of the literature. Clin Rheumatol 8:375–380PubMedCrossRef
10.
go back to reference International Study Group for Behçet’s disease (1992) Evaluation of diagnostic classification criteria in Behçet’s disease. Br J Rheumatol 31:299–308CrossRef International Study Group for Behçet’s disease (1992) Evaluation of diagnostic classification criteria in Behçet’s disease. Br J Rheumatol 31:299–308CrossRef
11.
go back to reference Gur-Toy G, Lenk N, Yalçın B, Aksaray S, Allı N (2005) Serum interleukin 8 as a serologic marker of activity in Behçet’s disease. Int J Dermatol 44(8):657–660PubMedCrossRef Gur-Toy G, Lenk N, Yalçın B, Aksaray S, Allı N (2005) Serum interleukin 8 as a serologic marker of activity in Behçet’s disease. Int J Dermatol 44(8):657–660PubMedCrossRef
12.
go back to reference Katsantonis J, Adler Y, Orfanos CE, Zoubolis CC et al (2000) Adamantiades–Behçet’s disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate. Dermatology 201:37–39PubMedCrossRef Katsantonis J, Adler Y, Orfanos CE, Zoubolis CC et al (2000) Adamantiades–Behçet’s disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate. Dermatology 201:37–39PubMedCrossRef
13.
go back to reference American Diabetes Association (1988) Report and recommendations of San Antonio Conference on diabetic neuropathy. Muscle Nerve 11:661–667CrossRef American Diabetes Association (1988) Report and recommendations of San Antonio Conference on diabetic neuropathy. Muscle Nerve 11:661–667CrossRef
14.
go back to reference Oh SH (1993) Nerve conduction techniques. In: Oh SH (ed) Clinical electromyography: nerve conduction studies, 2nd edn. Williams and Wilkins, Baltimore, pp 39–55 Oh SH (1993) Nerve conduction techniques. In: Oh SH (ed) Clinical electromyography: nerve conduction studies, 2nd edn. Williams and Wilkins, Baltimore, pp 39–55
15.
go back to reference Budak F, Efendi H, Apaydın R, Bilen N, Komsuoğlu S (2000) The F response parameters in Behçet’s disease. Electromyogr Clin Neurophysiol 40:45–48PubMed Budak F, Efendi H, Apaydın R, Bilen N, Komsuoğlu S (2000) The F response parameters in Behçet’s disease. Electromyogr Clin Neurophysiol 40:45–48PubMed
16.
go back to reference Akman-Demir G, Serdaroğlu P, Tasci B (1999) Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients, The Neuro–Behçet Study Group. Brain 122:2171–2182PubMedCrossRef Akman-Demir G, Serdaroğlu P, Tasci B (1999) Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients, The Neuro–Behçet Study Group. Brain 122:2171–2182PubMedCrossRef
17.
go back to reference O’Duffy JD, Carney JA, Deodhar S (1971) Behçet’s disease. Report of 10 cases, 3 with new manifestations. Ann Intern Med 75:561–570PubMed O’Duffy JD, Carney JA, Deodhar S (1971) Behçet’s disease. Report of 10 cases, 3 with new manifestations. Ann Intern Med 75:561–570PubMed
18.
go back to reference Birol A, Ulkatan S, Koçak M, Erkek E (2004) Peripheral neuropathy in Behçet’s disease. J Dermatol 31:455–459PubMed Birol A, Ulkatan S, Koçak M, Erkek E (2004) Peripheral neuropathy in Behçet’s disease. J Dermatol 31:455–459PubMed
19.
20.
go back to reference Oh SH (1993) Nerve conduction techniques. In: Oh SH (ed) Clinical electromyography: nerve conduction in polyneuropathies, 2nd edn. Williams and Wilkins, Baltimore, pp 575–666 Oh SH (1993) Nerve conduction techniques. In: Oh SH (ed) Clinical electromyography: nerve conduction in polyneuropathies, 2nd edn. Williams and Wilkins, Baltimore, pp 575–666
21.
go back to reference Sakane T, Suzuki N, Nagafuchi H (1997) Etiolopathology of Behçet’s disease: immunological aspects. Yonsei Med J 38:350–358PubMed Sakane T, Suzuki N, Nagafuchi H (1997) Etiolopathology of Behçet’s disease: immunological aspects. Yonsei Med J 38:350–358PubMed
22.
go back to reference Yoo WH, Kim HK, Park TS, Baek HS (2000) Mediastinal mass and brachial plexopathy caused by subclavian arterial aneurysm in Behçet’s disease. Rheumatology 19:227–230CrossRef Yoo WH, Kim HK, Park TS, Baek HS (2000) Mediastinal mass and brachial plexopathy caused by subclavian arterial aneurysm in Behçet’s disease. Rheumatology 19:227–230CrossRef
Metadata
Title
Peripheral neuropathy in Behçet disease: an electroneurophysiological study
Authors
Lale Akbulut
Gunes Gur
Hatice Bodur
Nuran Alli
Pınar Borman
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 8/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0466-0

Other articles of this Issue 8/2007

Clinical Rheumatology 8/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine